000 01362 a2200397 4500
005 20250511215219.0
264 0 _c19910328
008 199103s 0 0 eng d
022 _a0735-6757
024 7 _a10.1016/0735-6757(91)90174-i
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZell-Kanter, M
245 0 0 _aOral labetalol in hypertensive urgencies.
_h[electronic resource]
260 _bThe American journal of emergency medicine
_cMar 1991
300 _a136-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Oral
650 0 4 _aAdult
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aClinical Protocols
_xstandards
650 0 4 _aEmergencies
650 0 4 _aEmergency Service, Hospital
650 0 4 _aFemale
650 0 4 _aFurosemide
_xadministration & dosage
650 0 4 _aHospitals, University
650 0 4 _aHumans
650 0 4 _aHypertension
_xdrug therapy
650 0 4 _aIllinois
650 0 4 _aInjections, Intravenous
650 0 4 _aLabetalol
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMiddle Aged
700 1 _aLeikin, J B
773 0 _tThe American journal of emergency medicine
_gvol. 9
_gno. 2
_gp. 136-8
856 4 0 _uhttps://doi.org/10.1016/0735-6757(91)90174-i
_zAvailable from publisher's website
999 _c2001124
_d2001124